Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease

Georg Semmler, Christian Datz, Michael Trauner

Clin Mol Hepatol. 2023;29(Suppl):S244-S260. Published online December 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0364

View: 5371 Download: 298 Web of Science: 6 Crossref: 7

Correspondence

Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Clin Mol Hepatol. 2023;29(3):823-824. Published online May 31, 2023

DOI: https://doi.org/10.3350/cmh.2023.0182

View: 2155 Download: 44 Web of Science: 1 Crossref: 1

Original Article

Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo

Clin Mol Hepatol. 2023;29(3):721-732. Published online March 22, 2023

DOI: https://doi.org/10.3350/cmh.2023.0089

View: 14934 Download: 1,458 Web of Science: 107 Crossref: 135

Review

Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology

Sung Hak Lee, Hyun-Jong Jang

Clin Mol Hepatol. 2022;28(4):754-772. Published online April 21, 2022

DOI: https://doi.org/10.3350/cmh.2021.0394

View: 4805 Download: 230 Web of Science: 8 Crossref: 7

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2020;26(4):461-475. Published online September 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0136

View: 8265 Download: 277 Web of Science: 36 Crossref: 37

Personalized treatment of hepatitis B

Anna S. Lok

Clin Mol Hepatol. 2015;21(1):1-6. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.1

View: 8420 Download: 138 Web of Science: 18 Crossref: 17

Case Report

Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicines

Hyo Jeong Oh, Young Mi Mok, Moon Seong Baek, Ji Kyeong Lee, Bong Soo Seo, Tae Hyeon Kim, Keum Ha Choi, In Kyeom Hwang, Ji Eun Ra, Yong-Reol Oh, Yong Sung Kim, Eun Young Cho, Haak Cheoul Kim, Young Woo Sohn

Clin Mol Hepatol. 2013;19(3):305-308. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.305

View: 11231 Download: 96 Crossref: 5

Review

Drug-induced liver injury: present and future

Ki Tae Suk, Dong Joon Kim

Clin Mol Hepatol. 2012;18(3):249-257. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.249

View: 17694 Download: 304 Crossref: 98

3

The value of serum retinol-binding protein 4 Levels for determining disease severity in patients with chronic Liver disease

Jung Hyun Kwon, M.D., Seong Tae Park Gi Dae Kim, Ph.D. Chan Ran You, M.D., Jin Dong Kim, M.D., Hyun Young Woo, M.D., Jeong Won Jang, M.D. Chang Wook Kim, M.D., Si Hyun Bae, M.D., Jong Young Choi, M.D., Seung Kew Yoon, M.D.

Clin Mol Hepatol. 2009;15(1):59-69. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.59

View: 4901 Download: 61 Crossref: 9

4

Four cases of toxic Liver injury associated with Dictamnus dasycarpus

Jong Soon Jang, M.D., Eui Geun Seo, M.D., Cheol Han, M.D., Hee Bok Chae, M.D., Soon Je Kim, M.D. Jae Dong Lee, M.D. Joon Ho Wang, M.D.

Clin Mol Hepatol. 2008;14(2):206-212. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.206

View: 5460 Download: 69 Crossref: 23

3

The Survey for the Actual Condition of Drug Medication and Development of Health Care Cost Associated with Toxic Liver Injury in Korean; A Multicenter Study for the Detection and the Development of Nationwide Reporting System of Toxic Liver Injury

Tae Woo Yoo, M.D., Byung Ik Kim, M.D., Jin Bong Kim, M.D. Dong Joon Kim, M.D. Jae Woo Kim. Soon Koo Baik. Kwang Seok Kim, M.D. Gab Jin Cheon, M.D.

Clin Mol Hepatol. 2007;13(1):34-43. Published online January 1, 2000

View: 2608 Download: 28

1 |

Viewed By 5709	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4999	MAFLD: How is it different from NAFLD?
Viewed By 4753	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3858	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3849	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 104	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 82	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search